Profil
Jennifer Low currently works at 23andMe, Inc., as Head-Therapeutics Development from 2018.
Dr. Low also formerly worked at Genentech, Inc., as Senior Group Medical Director-Product Development from 2006 to 2014, Roche Holding AG, as Member, 23andMe Holding Co., as Head-Therapeutics Development, National Cancer Institute, as Senior Investigator, and Loxo Oncology, Inc., as Chief Medical Officer, EVP-Research & Development from 2014 to 2016.
Dr. Low received her graduate degree from Duke University, undergraduate degree from California Institute of Technology, and doctorate degree from Georgetown University.
Aktive Positionen von Jennifer Low
| Unternehmen | Position | Beginn |
|---|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Corporate Officer/Principal | 01.01.2018 |
Ehemalige bekannte Positionen von Jennifer Low
| Unternehmen | Position | Ende |
|---|---|---|
| CHROME HOLDING CO. | Corporate Officer/Principal | 01.01.2025 |
| LOXO ONCOLOGY INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.2014 |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Ausbildung von Jennifer Low
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
23andMe Holding Co.
23andMe Holding Co. BiotechnologyHealth Technology Operates as a genetic testing company | Health Technology |
















